Search clinical trials for: BI 655064 medium dose
Total 579 results
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
HealthCore-NERINational Heart, Lung, and Blood Institute (NHLBI); Transfusion Medicine/Hemostasis...CompletedThrombocytopeniaUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, France, Israel, Mexico, South Africa
-
Dr. Falk Pharma GmbHCompletedCrohn´s DiseaseGermany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan
-
Acerus Pharmaceuticals CorporationCompletedFemale Orgasmic DisorderUnited States, Canada, Australia
-
Boehringer IngelheimCompletedArthritis, Rheumatoid
-
Prim. Priv. Doz. Dr. Daniel CejkaMedice Arzneimittel Pütter GmbH & Co KGWithdrawnKidney Transplant; ComplicationsAustria
-
Jennifer Gassman, PhDNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); The...CompletedChronic Kidney DiseaseUnited States
-
Lumara Health, Inc.Completed
-
Sylentis, S.A.CompletedChoroidal Neovascularization | Safety, Tolerability and Pharmacokinetic Profile in Healthy VolunteersSpain
-
Boehringer IngelheimCompleted
-
OcugenNot yet recruitingDiabetic Macular Edema | Center Involved Diabetic Macular Edema
-
Osel, Inc.University of California, San FranciscoCompletedBacterial VaginosisUnited States
-
University Hospital, LilleRecruiting
-
Boehringer IngelheimCompleted
-
Hookipa Biotech GmbHCentre for Vaccinology Ghent - CEVACCompletedCytomegalovirus InfectionBelgium
-
Vascular Pharmaceuticals, Inc.CompletedDiabetic NephropathyUnited States, Puerto Rico
-
Pharvaris Netherlands B.V.RecruitingHereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditionsUnited States, Bulgaria, Czechia, Hungary, Spain, France, Germany, Poland, Canada, Israel
-
Israel Institute for Biological Research (IIBR)Completed
-
AbbVieBoehringer IngelheimCompleted
-
Merck Sharp & Dohme LLCCompleted
-
ST Pharm Co., Ltd.RecruitingHIV-1-infectionUnited States
-
GlaxoSmithKlineCureVacActive, not recruitingSARS-CoV-2Australia, United States
-
Novartis VaccinesCompleted
-
USDA Grand Forks Human Nutrition Research CenterCompletedOverweightUnited States
-
AbbVieBoehringer IngelheimCompleted
-
Cancer Research UKBioInvent International AB; BloodwiseCompletedB-cell Lymphoma | Waldenström Macroglobulinemia | Chronic Lymphocytic LeukaemiaUnited Kingdom
-
Seoul National University HospitalActive, not recruiting
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
AbbVieActive, not recruitingCrohn's DiseaseUnited States, Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Egypt, Estonia, France, Germany, Greece, Hong Kong, Ireland, Israel, Italy, Japan, Korea, Republic... and more
-
Supernus Pharmaceuticals, Inc.CompletedAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
Sinovac Research and Development Co., Ltd.Suspended
-
AtoGen Co. LtdATOGEN AUSTRALIA PTY LTDRecruitingBacterial Infections | Vaginal Disease | Vaginitis | Infection, Bacterial | Bacterial VaginosisAustralia
-
Yantai Yuhuangding HospitalRecruiting
-
Shanghai Greenvalley Pharmaceutical Co., Ltd.Shanghai Mental Health CenterCompletedCognitive Impairment | Alzheimer DiseaseChina
-
Merck Sharp & Dohme LLCCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
GlaxoSmithKlineCompletedRespiratory Syncytial Virus InfectionsUnited States, Belgium
-
Sinovac Biotech Co., LtdCompleted
-
Boehringer IngelheimCompleted
-
GlaxoSmithKlineActive, not recruitingSexually Transmitted DiseasesUnited States, Germany, Philippines, France, Spain, South Africa, United Kingdom, Brazil
-
Boehringer IngelheimCompleted
-
IntegoGen, LLCWithdrawnHidradenitis SuppurativaUnited States
-
Celon Pharma SANational Center for Research and Development, PolandCompleted
-
University of Texas Southwestern Medical CenterCompletedSymmetric Limited MorpheaUnited States
-
Sinovac Research and Development Co., Ltd.Withdrawn